Clinical Trial Update: Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating olaparib before surgery in localized prostate cancer; study terminated with posted results in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Prostate Cancer
• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• Olaparib (Olaparib)

Snippet

Sponsor: University of Washington | Conditions: Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage I Prostate Cancer AJCC v8 | Phase 2 | Status: TERMINATED | Results posted: 2020-09-21